aTyr Pharma gains as U.S. agency allows patent for antibodies

aTyr Pharma

29/09/2022 19:03

** Shares of aTyr Pharma Inc  LIFE.O  rise 5.5% to $2.89 
    ** U.S. Patent and Trademark Office provides notice of
allowance to co for a patent covering methods for use of
antibodies, called anti-neuropilin-2 (NRP2)  urn:newsml:reuters.com:*:nGNX75VMRn
    ** Co's patent application covers use of a series of
antibodies targeting NRP2 for therapeutic applications in areas
of cancer and inflammation
    ** NRP2 is a type of receptor in body that plays key role in
lymphatic development and in regulating inflammatory responses
    ** Including session's gain, stock down ~61% YTD
 (Reporting by Raghav Mahobe)
 ((Raghav.Mahobe@thomsonreuters.com;))